| 0 (0%) | 04-20 03:48 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 64.8 | 1-year : | 66.16 |
| Resists | First : | 55.48 | Second : | 56.65 |
| Pivot price | 55.15  |
|||
| Supports | First : | 53.59 | Second : | 44.59 |
| MAs | MA(5) : | 54.07 |
MA(20) : | 55.35 |
| MA(100) : | 53.17 |
MA(250) : | 51.88 |
|
| MACD | MACD : | -0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 8.3 |
D(3) : | 7.2 |
| RSI | RSI(14): 37.7 |
|||
| 52-week | High : | 56.65 | Low : | 46.9 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ FDT ] has closed above bottom band by 13.5%. Bollinger Bands are 77.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 54.32 - 54.58 | 54.58 - 54.84 |
| Low: | 52.99 - 53.33 | 53.33 - 53.66 |
| Close: | 53.27 - 53.8 | 53.8 - 54.32 |
Wed, 17 Apr 2024
Not All Forms of PPA Are FTD, as Recent High-Profile Case Highlights - AFTD
Wed, 17 Apr 2024
AFTD Ambassador Honors Daughter by Spreading FTD Awareness: “FTD Didn't Win in the End” - AFTD
Wed, 17 Apr 2024
Lexeo Therapeutics announces U.S. FDA granted FTD to LX2006 - TipRanks.com - TipRanks
Tue, 16 Apr 2024
AviadoBio treats first subject in trial of FTD-GRN therapy - Clinical Trials Arena
Mon, 15 Apr 2024
AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal ... - Business Wire
Mon, 01 Apr 2024
App May Pave Way to Treatments for No. 1 Dementia in Under-60s - UC San Francisco
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|